WhitTier Trust Company’s Teva Pharmaceuticals TEVA Stock Holding History

WhitTier Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-105	Closed	-$1.76K	–	1478
2025 Q2	$1.76K	Hold	105	–	–	﹤0.01%	1322
2025 Q1	$1.61K	Hold	105	–	–	﹤0.01%	1304
2024 Q4	$2.31K	Hold	105	–	–	﹤0.01%	1228
2024 Q3	$1.89K	Hold	105	–	–	﹤0.01%	1228
2024 Q2	$1.71K	Hold	105	–	–	﹤0.01%	1185
2024 Q1	$1.48K	Buy	+105	New	+$1.32K	﹤0.01%	1146
2022 Q3	–	Sell	-1,265	Closed	-$10K	–	1172
2022 Q2	$10K	Hold	1,265	–	–	﹤0.01%	929
2022 Q1	$12K	Hold	1,265	–	–	﹤0.01%	900
2021 Q4	$10K	Hold	1,265	–	–	﹤0.01%	911
2021 Q3	$12K	Hold	1,265	–	–	﹤0.01%	911
2021 Q2	$13K	Hold	1,265	–	–	﹤0.01%	843
2021 Q1	$15K	Hold	1,265	–	–	﹤0.01%	812
2020 Q4	$12K	Hold	1,265	–	–	﹤0.01%	815
2020 Q3	$11K	Hold	1,265	–	–	﹤0.01%	808
2020 Q2	$16K	Hold	1,265	–	–	﹤0.01%	744
2020 Q1	$11K	Hold	1,265	–	–	﹤0.01%	779
2019 Q4	$12K	Hold	1,265	–	–	﹤0.01%	813
2019 Q3	$9K	Sell	1,265 -55	-4%	-$421	﹤0.01%	838
2019 Q2	$12K	Hold	1,320	–	–	﹤0.01%	803
2019 Q1	$21K	Hold	1,320	–	–	﹤0.01%	732
2018 Q4	$20K	Hold	1,320	–	–	﹤0.01%	732
2018 Q3	$28K	Hold	1,320	–	–	﹤0.01%	698
2018 Q2	$32K	Sell	1,320 -1,271	-49%	-$25.9K	﹤0.01%	682
2018 Q1	$45K	Hold	2,591	–	–	﹤0.01%	632
2017 Q4	$50K	Sell	2,591 -71	-3%	-$1.07K	﹤0.01%	572
2017 Q3	$47K	Sell	2,662 -4,929	-65%	-$111K	﹤0.01%	554
2017 Q2	$252K	Sell	7,591 -55	-0.7%	-$1.7K	0.02%	321
2017 Q1	$246K	Hold	7,646	–	–	0.02%	321
2016 Q4	$277K	Buy	7,646 +3,113	+69%	+$124K	0.03%	301
2016 Q3	$209K	Sell	4,533 -955	-17%	-$49.8K	0.02%	329
2016 Q2	$276K	Hold	5,488	–	–	0.03%	305
2016 Q1	$293K	Hold	5,488	–	–	0.03%	293
2015 Q4	$360K	Sell	5,488 -400	-7%	-$24.7K	0.04%	272
2015 Q3	$333K	Buy	5,888 +1,300	+28%	+$84.3K	0.04%	284
2015 Q2	$271K	Hold	4,588	–	–	0.03%	321
2015 Q1	$286K	Hold	4,588	–	–	0.03%	320
2014 Q4	$264K	Hold	4,588	–	–	0.03%	324
2014 Q3	$247K	Buy	4,588 +50	+1%	+$2.65K	0.03%	314
2014 Q2	$237K	Sell	4,538 -4,415	-49%	-$226K	0.03%	319
2014 Q1	$474K	Sell	8,953 -1,815	-17%	-$83.9K	0.06%	245
2013 Q4	$432K	Sell	10,768 -86,644	-89%	-$3.41M	0.05%	244
2013 Q3	$3.68M	Buy	97,412 +11,154	+13%	+$435K	0.49%	63
2013 Q2	$3.38M	Buy	+86,258	New	+$3.36M	0.49%	62

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

WhitTier Trust Company's TEVA Position: Q3 2025 in Review

WhitTier Trust Company sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 105 shares — an estimated $1.76K sold.

WhitTier Trust Company first reported a position in TEVA in Q2 2013 and held it in 43 quarters. The position peaked at $3.68M in Q3 2013. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

WhitTier Trust Company reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
WhitTier Trust Company sold 105 Teva Pharmaceuticals shares in Q3 2025, an estimated $1.76K.
WhitTier Trust Company first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 43 quarters.
WhitTier Trust Company's Teva Pharmaceuticals position peaked at $3.68M in Q3 2013.
550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.